IFIH1 and interstitial lung disease: The typical clinical manifestations of adult IIM patients with anti-MDA5 antibodies were amyopathic myositis with rapidly progressive interstitial lung disease (ILD), which in turn determines a high mortality rate in these patients (Figure 4).